Estrella Immunopharma Statistics
Share Statistics
Estrella Immunopharma has -
shares outstanding. The number of shares has increased by -0.58%
in one year.
Shares Outstanding | n/a |
Shares Change (YoY) | -0.58% |
Shares Change (QoQ) | -0.04% |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 3,069 |
FTD / Avg. Volume | 5.99% |
Short Selling Information
The latest short interest is 2.74K, so 0.01% of the outstanding
shares have been sold short.
Short Interest | 2.74K |
Short % of Shares Out | 0.01% |
Short % of Float | 0.03% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -5.3 and the forward
PE ratio is -2.22.
Estrella Immunopharma's PEG ratio is
-0.23.
PE Ratio | -5.3 |
Forward PE | -2.22 |
PS Ratio | 0 |
Forward PS | n/a |
PB Ratio | 9.06 |
P/FCF Ratio | -2.41 |
PEG Ratio | -0.23 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Estrella Immunopharma.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.65,
with a Debt / Equity ratio of 0.
Current Ratio | 24.65 |
Quick Ratio | 24.65 |
Debt / Equity | 0 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | undefined |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 1.63K |
Effective Tax Rate | -0.02% |
Stock Price Statistics
The stock price has increased by -8.1% in the
last 52 weeks. The beta is 0.37, so Estrella Immunopharma's
price volatility has been higher than the market average.
Beta | 0.37 |
52-Week Price Change | -8.1% |
50-Day Moving Average | 0.97 |
200-Day Moving Average | 1.05 |
Relative Strength Index (RSI) | 35.56 |
Average Volume (20 Days) | 51,225 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -7.31M |
Net Income | -7.31M |
EBITDA | -7.31M |
EBIT | -7.31M |
Earnings Per Share (EPS) | -0.21 |
Full Income Statement Balance Sheet
The company has 4.17M in cash and 0 in
debt, giving a net cash position of 4.17M.
Cash & Cash Equivalents | 4.17M |
Total Debt | n/a |
Net Cash | n/a |
Retained Earnings | -19.5M |
Total Assets | 3.74M |
Working Capital | -753.71K |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -16.07M
and capital expenditures -4, giving a free cash flow of -16.07M.
Operating Cash Flow | -16.07M |
Capital Expenditures | -4 |
Free Cash Flow | -16.07M |
FCF Per Share | -0.46 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |